Surgical Innovations Group Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0004016704
GBP
0.01
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 5.45%, its profits have fallen by -11%
2

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 5 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

-4.98%

stock-summary
Price to Book

0.63

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.14%
0%
-17.14%
6 Months
-17.14%
0%
-17.14%
1 Year
5.45%
0%
5.45%
2 Years
-35.56%
0%
-35.56%
3 Years
-64.85%
0%
-64.85%
4 Years
-75.83%
0%
-75.83%
5 Years
-62.58%
0%
-62.58%

Surgical Innovations Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.72%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
-0.67
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.93
Tax Ratio
5.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.14%
ROE (avg)
0.54%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.63
EV to EBIT
-6.34
EV to EBITDA
6.34
EV to Capital Employed
0.67
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.73%
ROE (Latest)
-4.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Surgical Innovations Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.19% vs 24.18% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -266.67% vs 160.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.00",
          "val2": "11.30",
          "chgp": "6.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.20",
          "val2": "0.70",
          "chgp": "-71.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.50",
          "val2": "0.30",
          "chgp": "-266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-49.60%",
          "val2": "13.70%",
          "chgp": "-6.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
12.00
11.30
6.19%
Operating Profit (PBDIT) excl Other Income
0.20
0.70
-71.43%
Interest
0.10
0.10
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-0.50
0.30
-266.67%
Operating Profit Margin (Excl OI)
-49.60%
13.70%
-6.33%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 6.19% vs 24.18% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -266.67% vs 160.00% in Dec 2022

stock-summaryCompany CV
About Surgical Innovations Group Plc stock-summary
stock-summary
Surgical Innovations Group Plc
Pharmaceuticals & Biotechnology
Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The Company operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of minimally invasive technology products for PE applications.
Company Coordinates stock-summary
Company Details
Clayton Wood House, 6 Clayton Wood Bank , LEEDS None : LS16 6QZ
stock-summary
Tel: 44 113 2307597
stock-summary
Registrar Details